{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:01:00Z","timestamp":1790654460684,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10528-026-11336-y","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T10:47:56Z","timestamp":1771411676000},"page":"6110-6124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Leish-F1 Multi-epitope Lentiviral Vaccine as a Novel Candidate Against Leishmania major in Balb\/c Mice"],"prefix":"10.1007","volume":"64","author":[{"given":"Rasoul","family":"Daneshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Rabienia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Roudbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdolmajid","family":"Ghasemian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Moulazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Mortazavidehkordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akbar","family":"Farjadfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"11336_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2009.46","author":"JTST Andreadis","year":"2009","unstructured":"Andreadis JTST (2009) Independent and high-level dual-gene expression in adult stem-progenitor cells from a single lentiviral vector. Gene Ther. https:\/\/doi.org\/10.1038\/gt.2009.46","journal-title":"Gene Ther"},{"key":"11336_CR2","doi-asserted-by":"publisher","first-page":"103802","DOI":"10.1016\/j.cellimm.2018.04.012","volume":"342","author":"A Annoni","year":"2019","unstructured":"Annoni A et al (2019) Modulation of immune responses in lentiviral vector-mediated gene transfer. Cell Immunol 342:103802","journal-title":"Cell Immunol"},{"key":"11336_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13090812","author":"A Ayala","year":"2024","unstructured":"Ayala A et al (2024) Advances in Leishmania vaccines: current development and future prospects. Pathogens. https:\/\/doi.org\/10.3390\/pathogens13090812","journal-title":"Pathogens"},{"key":"11336_CR4","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3389\/fimmu.2018.01043","volume":"9","author":"RCF De Brito","year":"2018","unstructured":"De Brito RCF et al (2018) Peptide vaccines for leishmaniasis. Front Immunol 9:1043","journal-title":"Front Immunol"},{"key":"11336_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020252","author":"RCF Brito","year":"2020","unstructured":"Brito RCF et al (2020) Chimeric vaccines designed by immunoinformatics-activated polyfunctional and memory T cells that trigger protection against experimental visceral leishmaniasis. Vaccines. https:\/\/doi.org\/10.3390\/vaccines8020252","journal-title":"Vaccines"},{"issue":"27\u201328","key":"11336_CR6","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1016\/j.vaccine.2006.03.023","volume":"24","author":"M Calvopina","year":"2006","unstructured":"Calvopina M et al (2006) Efficacy of vaccination with a combination of leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against leishmania amazonensis infection in a murine model of new world cutaneous leishmaniasis. Vaccine 24(27\u201328):5645\u20135652","journal-title":"Vaccine"},{"issue":"1","key":"11336_CR7","doi-asserted-by":"publisher","first-page":"18653","DOI":"10.1038\/s41598-020-75410-0","volume":"10","author":"P Cecilio","year":"2020","unstructured":"Cecilio P et al (2020) Engineering a vector-based pan-Leishmania vaccine for humans: proof of principle. Sci Rep 10(1):18653","journal-title":"Sci Rep"},{"issue":"9","key":"11336_CR8","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.1128\/IAI.00394-07","volume":"75","author":"RN Coler","year":"2007","unstructured":"Coler RN et al (2007) Leish-111f, a Recombinant polyprotein vaccine that protects against visceral leishmaniasis by elicitation of CD4\u2009+\u2009T cells. Infect Immun 75(9):4648\u20134654","journal-title":"Infect Immun"},{"issue":"8","key":"11336_CR9","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1128\/IAI.70.8.4215-4225.2002","volume":"70","author":"RN Coler","year":"2002","unstructured":"Coler RN et al (2002) Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, leishmania major stress-inducible protein 1, and leishmania elongation initiation factor protects against leishmaniasis. Infect Immun 70(8):4215\u20134225","journal-title":"Infect Immun"},{"key":"11336_CR10","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.3389\/fimmu.2018.03001","volume":"9","author":"LP Covre","year":"2018","unstructured":"Covre LP et al (2018) Circulating senescent T cells are linked to systemic inflammation and lesion size during human cutaneous leishmaniasis. Front Immunol 9:3001","journal-title":"Front Immunol"},{"key":"11336_CR11","doi-asserted-by":"crossref","unstructured":"Dikhit MR et al (2018) The potential HLA class I-restricted epitopes derived from LeIF and TSA of leishmania donovani evoke anti-leishmania CD8\u2009+\u2009T lymphocyte response. Sci Rep 8(1):14175","DOI":"10.1038\/s41598-018-32040-x"},{"issue":"5","key":"11336_CR12","doi-asserted-by":"publisher","first-page":"e0004545","DOI":"10.1371\/journal.pntd.0004545","volume":"10","author":"R Du","year":"2016","unstructured":"Du R et al (2016) Old world cutaneous leishmaniasis and refugee crises in the middle East and North Africa. PLoS Negl Trop Dis 10(5):e0004545","journal-title":"PLoS Negl Trop Dis"},{"key":"11336_CR13","doi-asserted-by":"publisher","first-page":"2496713","DOI":"10.1155\/2020\/2496713","volume":"2020","author":"T Dubie","year":"2020","unstructured":"Dubie T, Mohammed Y (2020) Review on the role of host immune response in protection and Immunopathogenesis during cutaneous leishmaniasis infection. J Immunol Res 2020:2496713","journal-title":"J Immunol Res"},{"key":"11336_CR14","doi-asserted-by":"crossref","unstructured":"De Groot AS (2009) Epitope-Based Immunome-Derived Vaccines: A Strategy for Improved Design and Safety. Clinical Applications of Immunomics. pp 39\u201369","DOI":"10.1007\/978-0-387-79208-8_3"},{"key":"11336_CR15","doi-asserted-by":"publisher","first-page":"7031492","DOI":"10.1155\/2021\/7031492","volume":"2021","author":"A Fallah","year":"2021","unstructured":"Fallah A et al (2021) Overexpression effects of miR-424 and BMP2 on the osteogenesis of wharton\u2019s Jelly-Derived stem cells. Biomed Res Int 2021:7031492","journal-title":"Biomed Res Int"},{"key":"11336_CR16","unstructured":"Shantanabha Das AF, Boussoffara T, Das S, Oswald D, Losch FO, Selka M, Sacerdoti-Sierra N, Sch\u00f6nian G, Wiesm\u00fcller K-H, Seifert K, Schroff M, Juhls C, Jaffe CL, Croft SL (2015) Farrokh Modabber, Peter Walden, Modular multiantigen T cell Epitope\u2013Enriched DNA vaccine against human leishmaniasis. Science Translational Medicine"},{"key":"11336_CR17","doi-asserted-by":"crossref","unstructured":"Himanshu Kaushal RB-G, Singh Negi N, Lemesre J-L (2014) G\u00e9rard Papierok and Poonam Salotra, Role of CD8\u2009+\u2009T cells in protection against leishmania donovani infection in healed visceral leishmaniasis individuals. BMC Infecious Diseases","DOI":"10.1186\/s12879-014-0653-6"},{"key":"11336_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/DDDT.S146521","volume":"12","author":"M Ghorbani","year":"2018","unstructured":"Ghorbani M, Farhoudi R (2018) Leishmaniasis in humans: drug or vaccine therapy? Drug Des Devel Ther 12:25\u201340","journal-title":"Drug Des Devel Ther"},{"issue":"26","key":"11336_CR19","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1016\/j.vaccine.2015.12.071","volume":"34","author":"PM Gillespie","year":"2016","unstructured":"Gillespie PM et al (2016) Status of vaccine research and development of vaccines for leishmaniasis. Vaccine 34(26):2992\u20132995","journal-title":"Vaccine"},{"key":"11336_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.micpath.2018.03.057","volume":"119","author":"N Hashemi","year":"2018","unstructured":"Hashemi N et al (2018) Locked nucleic acid -anti- let-7a induces apoptosis and necrosis in macrophages infected with leishmania major. Microb Pathog 119:193\u2013199","journal-title":"Microb Pathog"},{"key":"11336_CR21","doi-asserted-by":"publisher","first-page":"1269774","DOI":"10.3389\/fimmu.2023.1269774","volume":"14","author":"R Jyotisha","year":"2023","unstructured":"Jyotisha R, Qureshi, Qureshi IA (2023) Development of a multi-epitope vaccine candidate for leishmanial parasites applying immunoinformatics and in vitro approaches. Front Immunol 14:1269774","journal-title":"Front Immunol"},{"issue":"4","key":"11336_CR22","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/pim.12176","volume":"37","author":"H Kaur","year":"2015","unstructured":"Kaur H, Thakur A, Kaur S (2015) Studies on cocktails of 31-kDa, 36-kDa and 51-kDa antigens of leishmania donovani along with saponin against murine visceral leishmaniasis. Parasite Immunol 37(4):192\u2013203","journal-title":"Parasite Immunol"},{"issue":"8","key":"11336_CR23","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nrmicro2608","volume":"9","author":"P Kaye","year":"2011","unstructured":"Kaye P, Scott P (2011) Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol 9(8):604\u2013615","journal-title":"Nat Rev Microbiol"},{"issue":"Suppl","key":"11336_CR24","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1017\/S0031182006001831","volume":"133","author":"L Kedzierski","year":"2006","unstructured":"Kedzierski L, Zhu Y, Handman E (2006) Leishmania vaccines: progress and problems. Parasitology 133(Suppl):S87\u2013112","journal-title":"Parasitology"},{"key":"11336_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-04064-8","author":"MAA Khan","year":"2020","unstructured":"Khan MAA et al (2020) An immunoinformatic approach driven by experimental proteomics: in silico design of a subunit candidate vaccine targeting secretory proteins of Leishmania donovani amastigotes. Parasit Vectors. https:\/\/doi.org\/10.1186\/s13071-020-04064-8","journal-title":"Parasit Vectors"},{"issue":"4","key":"11336_CR26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nprot.2009.22","volume":"4","author":"RH Kutner","year":"2009","unstructured":"Kutner RH, Zhang XY, Reiser J (2009) Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc 4(4):495\u2013505","journal-title":"Nat Protoc"},{"issue":"8","key":"11336_CR27","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/mt.2009.130","volume":"17","author":"MO Lasaro","year":"2009","unstructured":"Lasaro MO, Ertl HC (2009) New insights on adenovirus as vaccine vectors. Mol Ther 17(8):1333\u20131339","journal-title":"Mol Ther"},{"issue":"1\u20133","key":"11336_CR28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ejphar.2010.02.055","volume":"635","author":"FP Lee","year":"2010","unstructured":"Lee FP et al (2010) Ayanin, a non-selective phosphodiesterase 1\u20134 inhibitor, effectively suppresses ovalbumin-induced airway hyperresponsiveness without affecting xylazine\/ketamine-induced anesthesia. Eur J Pharmacol 635(1\u20133):198\u2013203","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"11336_CR29","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.virol.2006.03.033","volume":"351","author":"Z Liu","year":"2006","unstructured":"Liu Z et al (2006) Immunoprophylaxis against AIDS in macaques with a lentiviral DNA vaccine. Virology 351(2):444\u2013454","journal-title":"Virology"},{"issue":"46","key":"11336_CR30","doi-asserted-by":"publisher","first-page":"7427","DOI":"10.1016\/j.vaccine.2010.08.092","volume":"28","author":"A Llanos-Cuentas","year":"2010","unstructured":"Llanos-Cuentas A et al (2010) A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1\u2009+\u2009MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis. Vaccine 28(46):7427\u20137435","journal-title":"Vaccine"},{"key":"11336_CR31","doi-asserted-by":"crossref","unstructured":"Mohammad Estiri BE, Fallah A, Aghazadeh M, Sedaqati A, Abdollahi A (2022) Mahsa Rabienia, Nahid Mortazavidehkordi and Akbar Farjadfar, Therapeutic effects of mesenchymal stem cells expressing erythropoietin on cancerrelated anemia in mice model. Current Gene Therapy","DOI":"10.21203\/rs.3.rs-84099\/v3"},{"issue":"11","key":"11336_CR32","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/pim.12356","volume":"38","author":"N Mortazavidehkordi","year":"2016","unstructured":"Mortazavidehkordi N et al (2016) Evaluation of a novel lentiviral vaccine expressing KMP11-HASPB fusion protein against leishmania infantum in BALB\/c mice. Parasite Immunol 38(11):670\u2013677","journal-title":"Parasite Immunol"},{"issue":"19","key":"11336_CR33","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/j.vaccine.2015.03.021","volume":"33","author":"M Moussa","year":"2015","unstructured":"Moussa M et al (2015) A novel non-integrative single-cycle chimeric HIV lentivector DNA vaccine. Vaccine 33(19):2273\u20132282","journal-title":"Vaccine"},{"issue":"40","key":"11336_CR34","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1016\/j.vaccine.2010.07.063","volume":"28","author":"E Nascimento","year":"2010","unstructured":"Nascimento E et al (2010) A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1\u2009+\u2009MPL-SE vaccine when used in combination with Meglumine antimoniate for the treatment of cutaneous leishmaniasis. Vaccine 28(40):6581\u20136587","journal-title":"Vaccine"},{"issue":"6","key":"11336_CR35","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/elps.202000306","volume":"42","author":"A Ntoukas","year":"2021","unstructured":"Ntoukas A et al (2021) A quantitative Western blot technique using TMB: comparison with the conventional technique. Electrophoresis 42(6):786\u2013792","journal-title":"Electrophoresis"},{"issue":"5","key":"11336_CR36","doi-asserted-by":"publisher","first-page":"e0005527","DOI":"10.1371\/journal.pntd.0005527","volume":"11","author":"M Osman","year":"2017","unstructured":"Osman M et al (2017) A third generation vaccine for human visceral leishmaniasis and post Kala Azar dermal leishmaniasis: First-in-human trial of ChAd63-KH. PLoS Negl Trop Dis 11(5):e0005527","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"11336_CR37","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/pim.12147","volume":"36","author":"L Pirdel","year":"2014","unstructured":"Pirdel L, Hosseini AZ, Rasouli M (2014) Immune response in susceptible BALB\/c mice immunized with DNA encoding lipophosphoglycan 3 of leishmania infantum. Parasite Immunol 36(12):700\u2013707","journal-title":"Parasite Immunol"},{"issue":"1","key":"11336_CR38","doi-asserted-by":"publisher","first-page":"e0295495","DOI":"10.1371\/journal.pone.0295495","volume":"19","author":"M Rabienia","year":"2024","unstructured":"Rabienia M et al (2024) Designing of a new multi-epitope vaccine against leishmania major using Leish-F1 epitopes: an In-silico study. PLoS ONE 19(1):e0295495","journal-title":"PLoS ONE"},{"key":"11336_CR39","doi-asserted-by":"publisher","first-page":"105423","DOI":"10.1016\/j.ejps.2020.105423","volume":"152","author":"M Rabienia","year":"2020","unstructured":"Rabienia M et al (2020) Exploring membrane proteins of leishmania major to design a new multi-epitope vaccine using immunoinformatics approach. Eur J Pharm Sci 152:105423","journal-title":"Eur J Pharm Sci"},{"key":"11336_CR40","doi-asserted-by":"publisher","first-page":"1203355","DOI":"10.3389\/fmicb.2023.1203355","volume":"14","author":"N Rcheulishvili","year":"2023","unstructured":"Rcheulishvili N et al (2023) Design, evaluation, and immune simulation of potentially universal multi-epitope Mpox vaccine candidate: focus on DNA vaccine. Front Microbiol 14:1203355","journal-title":"Front Microbiol"},{"key":"11336_CR41","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01422-19","author":"F Rodriguez","year":"2020","unstructured":"Rodriguez F et al (2020) In vitro and in vivo characterization of potent antileishmanial methionine aminopeptidase 1 inhibitors. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.01422-19","journal-title":"Antimicrob Agents Chemother"},{"issue":"34","key":"11336_CR42","doi-asserted-by":"publisher","first-page":"323","DOI":"10.25259\/IJMR_1040_2024","volume":"160","author":"S Shital","year":"2024","unstructured":"Shital S et al (2024) An update on Recombinant vaccines against leishmaniasis. Indian J Med Res 160(34):323\u2013337","journal-title":"Indian J Med Res"},{"issue":"19","key":"11336_CR43","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1016\/j.vaccine.2010.02.089","volume":"28","author":"J Trigo","year":"2010","unstructured":"Trigo J et al (2010) Treatment of canine visceral leishmaniasis by the vaccine Leish-111f\u2009+\u2009MPL-SE. Vaccine 28(19):3333\u20133340","journal-title":"Vaccine"},{"key":"11336_CR44","doi-asserted-by":"crossref","unstructured":"Barde I, Salmon P, Trono D Production and Titration of lentiviral vectors. Curr Protoc Neurosci 2010 Chapter 4: p. Unit 4 21.","DOI":"10.1002\/0471142301.ns0421s53"},{"issue":"9","key":"11336_CR45","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.1128\/JVI.76.9.4580-4590.2002","volume":"76","author":"AK Zaiss","year":"2002","unstructured":"Zaiss AK et al (2002) Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J Virol 76(9):4580\u20134590","journal-title":"J Virol"},{"issue":"1","key":"11336_CR46","doi-asserted-by":"publisher","first-page":"2352908","DOI":"10.1080\/21645515.2024.2352908","volume":"20","author":"L Zhu","year":"2024","unstructured":"Zhu L et al (2024) Design and evaluation of a multi-epitope DNA vaccine against HPV16. Hum Vaccin Immunother 20(1):2352908","journal-title":"Hum Vaccin Immunother"},{"key":"11336_CR47","unstructured":"https:\/\/www.who.int\/health-topics\/leishmaniasis\/the-global-epidemiology-ofleishmaniasis#tab. (2025)"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-026-11336-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-026-11336-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-026-11336-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T08:08:41Z","timestamp":1784621321000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-026-11336-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["11336"],"URL":"https:\/\/doi.org\/10.1007\/s10528-026-11336-y","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was done based on the specific National Ethical Guidelines for Biomedical Research issued by the Research and Technology Deputy of Ministry of Health and Medicinal Education (MOHME) of Iran (2005) and accordance with ARRIVE guidelines (\n                      \n                      ). This study was approved by Fasa University of Medical Sciences (IR.FUMS.REC.1398.129).","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have the consent for publication.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}